簡易檢索 / 詳目顯示

研究生: 李映瑩
Lee, Ying-ying
論文名稱: 纖維母細胞生長因子-9對MA-10小鼠萊氏腫瘤細胞固醇類生成之影響
The effect of fibroblast growth factor-9 on steroidogenesis in MA-10 mouse Leydig tumor cell line
指導教授: 黃步敏
Huang, Bu-Miin
蔡少正
Tsai, Shaw-Jenq
學位類別: 碩士
Master
系所名稱: 醫學院 - 細胞生物與解剖學研究所
Institute of Cell Biology and Anatomy
論文出版年: 2007
畢業學年度: 95
語文別: 中文
論文頁數: 81
中文關鍵詞: 纖維母細胞生長因子-9MA-10小鼠萊氏腫瘤細胞
外文關鍵詞: fibroblast growth factor-9, steroidogenesis, MA-10 mouse Leydig tumor cell line
相關次數: 點閱:143下載:2
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 先前的研究文獻指出,纖維母細胞生長因子-9 是神經細胞、前列腺細胞以及肺間質細胞的致裂原生長因子,可受類固醇賀爾蒙的調控,進而增加促性腺激素刺激生殖腺類固醇生成細胞的類固醇分泌。在生物胚胎發育時期,缺乏纖維母細胞生長因子-9 表現的小鼠,其性別轉換有從雄性轉變成為雌性,睪丸曲細精管發育不全的情況發生。顯示出纖維母細胞生長因子-9 在類固醇生成上扮演很重要的角色。我們先前的研究結果指出,在未成熟的雄性小鼠萊氏細胞,纖維母細胞生長因子-9是藉由結合到特定的纖維母細胞生長因子接受器3lllc,進一步的透過活化Ras-MAPK,PI3K以及PKA訊息傳遞機制而增加固醇類生合成急性調控蛋白表現以及睪固酮的生合成產量。然而,纖維母細胞生長因子-9刺激睪固酮的生成是透過如何調控固醇類生合成急性調控蛋白基因表現的分子調控機制,至今仍然未有定論。因此,本篇論文的目的在於探討纖維母細胞生長因子-9是否是透過活化依賴性環狀單磷酸環腺苷相關的轉錄因子去調控固醇類生合成急性調控蛋白啟動子上的特殊片段,而影響固醇類的生合成。近期內分泌分子機制的研究,常使用MA-10小鼠萊氏腫瘤細胞株作為動物細胞模式,由於此細胞株的17α羥化酶酵素量很低,所以偵測黃體酮為固醇類最終產物。結果顯示,隨著濃度的增加,纖維母細胞生長因子-9具有刺激黃體酮的生成。另外,我們在MA-10小鼠的萊氏腫瘤細胞上也偵測到FGFR2lllb, FGFR2lllc, FGFR3lllb, 以及FGFR3lllc這四種纖維母細胞生長因子接受器傳訊著核醣核酸的表現。西方點墨法結果顯示,纖維母細胞生長因子-9能有效刺激固醇類生合成急性調控蛋白的蛋白表現。進一步,我們使用已建構完成的載體,此載體帶有冷光酶的報導基因及全長1.3 kb的固醇類生合成急性調控蛋白啟動子的基因序列,將其轉植入MA-10小鼠的萊氏腫瘤細胞大量表現。根據測量轉殖後啟動子的活性結果,顯示纖維母細胞生長因子-9無法調控固醇類生合成急性調控蛋白啟動子的轉錄活性。然而,文獻顯示,在MA-10小鼠的萊氏腫瘤細胞中,經由環狀單磷酸環腺苷刺激固醇類的生合成機制是透過ERK 1/2 MEPK kinase磷酸化,繼而促使固醇類生合成急性調控蛋白基因的轉錄。相同的,我們證實在MA-10小鼠的萊氏腫瘤細胞中,纖維母細胞生長因子-9能有效刺激ERK 1/2 MAPK kinase的磷酸化,此磷酸化的現象可被我們加入的MAPK抑制劑U0126而抑制。 然而,MAPK抑制劑對纖維母細胞生長因子-9調控固醇類生合成急性調控蛋白的表現仍待未來進一步研究。總結,這些結果指出在MA-10小鼠的萊氏腫瘤細胞,纖維母細胞生長因子-9可能是透過調控MEPK-ERK訊息傳遞路徑,進而影響固醇類的生合成。

    Previous studies demonstrated that FGF-9 was a steroid-regulated mitogen and survival factor for nerve cells, prostatic cells and lung mesenchymal cells. Besides, FGF-9 could modulate gonadotropin- stimulated steroid secretion in gonadal steroidogenic cells. During embryogenesis, FGF-9-knockout mice exhibited male-to-female sex reversal and seminiferous tubles hypoplasia in testis. These results indicated the critical role of FGF-9 on steroidogenesis. Our previous results demonstrated that FGF-9 increased the StAR expression and testosterone production by binding to fibroblast growth factor receptor 3IIIc (FGFR3IIIc) and activating through Ras-MAPK, PI3K and PKA signaling pathways in immature mouse Leydig cells. However, the molecular mechanism on transcriptional level of StAR gene expression in FGF-9-stimulated testosterone production remains unclear. Thus, the aim of this study is to investigate the steroidogenic effects by FGF-9 whether go through activating cAMP-dependent transcription factors to regulate the specific element of StAR promoter. In the present study, MA-10 mouse Leydig tumor cell line was used to investigate the molecular mechanism. Results show that progesterone production was increased by FGF-9. In addition, four type FGF-9 receptors, 2IIIb, 2IIIc, 3IIIb and 3IIIc, were expressed in MA-10 mouse Leydig tumor cells. Using immunoblotting assays, FGF-9 could also increase StAR protein expression. Furthermore, MA-10 mouse Leydig tumor cells were transiently transfected with plasmid containing luciferase gene with 5’-flanking 1.3kb StAR (-1278 ~ +32) promoter segments, which illustrated that FGF-9 did not regulate StAR promoter activity. However, FGF-9 might activate phosphorylation of ERK1, 2, MAP kinases pathway. Taken together, these data indicated that FGF9 might go through MEK-ERK signaling pathway to increase progesterone production rather than activate StAR promoter activity in MA-10 cells.

    摘要---------------------------------------------------------------------------------- 中文----------------------------------------------------------------------------------I 英文--------------------------------------------------------------------------------III 致謝--------------------------------------------------------------------------------V 目錄-------------------------------------------------------------------------------VI 表錄-------------------------------------------------------------------------------IX 圖錄--------------------------------------------------------------------------------X 序論---------------------------------------------------------------------------------1 實驗方法-------------------------------------------------------------------------13 a.細胞培養-----------------------------------------------------------------------13 b.放射線免疫分析法 (Radioimmunoassay; RIA)-------------------------13 c.蛋白質濃度之分析---------------------------------------------------------------14 d.SDS-PAGE 蛋白質電泳與西方轉漬 (Western blotting)--------------15 e.細胞中 total RNA 之純化--------------------------------------------------16 f.反轉錄聚合酶連鎖反應 (Reverse transcription-polymerse chain Reaction; RT-PCR)-------------------------------17 g.準備小量質體DNA (Midipreparation of plasmid DNA)----------------18 h.細胞轉殖 (Transient transfection) 以及螢光酵素檢測 (luciferase assay)------------------------------------- 19 i.統計分析------------------------------------------------------------------------21 結果--------------------------------------------------------------------------------21 纖維母細胞生長因子-9對MA-10小鼠萊氏腫瘤細胞誘導黃體酮生成之劑量影響-----------------------------------------------------------------------24 MA-10小鼠萊氏腫瘤細胞中偵測纖維母細胞生長因子接受器傳訊者( FGFR2IIIb, FGFR2lllc ,FGFR3IIIb以及FGFR3IIIc)核醣核酸的表現量----------------------------------------------------------------------24 MA-10小鼠萊氏腫瘤細胞中纖維母細胞生長因子-9調節固醇類生合成急性調控蛋白的蛋白表現影響--------------------------------------------25 MA-10小鼠萊氏腫瘤細胞中纖維母細胞生長因子-9對固醇類生合成急性調控蛋白啟動子的活性影響--------------------------------------------26 MA-10小鼠萊氏腫瘤細胞中纖維母細胞生長因子-9誘導ERK1/2蛋白質磷酸化的影響-----------------------------------------------------------------27 討論------------------------------------------------------------------------------- 28 附錄(一):藥品的配置----------------------------------------------------------58 A.細胞培養相關溶液-----------------------------------------------------------58 B.蛋白質分析相關溶液--------------------------------------------------------59 C.放射線免疫分析法分析相關溶液-----------------------------------------63 附錄(二):使用藥品廠牌一覽表---------------------------------------------65 附錄(三):本論文中所使用到的抗體資料---------------------------------68 參考文獻------------------------------------------------------------------------- 33 作者資料------------------------------------------------------------------------- 69

    Arakane F, Sugawara T, Nishino H,Liu Z, Holt JA, Pain D, Stocco DM, Miller WL, Strauss JF. 1996 Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: implications for the mechanism of StAR action. Proc. Natl. Acad. Sci. USA,
    93: 13731–13736.

    Avivi A, Yayon A, Givol D. 1993 A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III. FEBS Lett 330: 249–252.

    Baulieu EE. 1997 Neurosteroids: Of the nervous system, by the nervous system, for the nervous system. Recent Progress in Hormone Research 52: 1-32.

    Bertrand V, Hudson C, Caillol D, Popovici C, and Lemaire P. 2003 Neural tissue in ascidian embryos is induced by FGF9/16/20, acting via a combination of maternal GATA and Ets transcription factors. Cell 115: 615–627.

    Berridge M.J. 1993 Cell signaling. A tale of two messengers. Nature 365: 388-399.

    Bose HS, Sato S, Aisenberg J, Shalev SA, Matsuo N, and Miller WL. 2000 Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia. J. Clin. Endocrinol. Metab. 85: 3636–3639.

    Burgar HR, Burns HD, Elsden JL, Lalioti MD, Heath JK. 2002 Association of the signaling adaptor FRS2 with fibroblast growth factor receptor 1 (FGFR1) is mediated by alternative splicing of the juxtamembrane domain. J. Biol. Chem. 277: 4018–4023.

    Cancilla B, Risbridger GP. 1998 Differential Localization of Fibroblast Growth Factor Receptor-1, -2, -3, and -4 in Fetal, Immature, and Adult Rat Testes. Biol. Reprod. 58: 1138-1145.

    Caron KM, Ikeda Y, Soo SC, Stocco DM, Parker KL, Clark BJ. 1997 Characterization of the promoter region of the mouse gene encoding the steroidogenic acute regulatory protein. Mol. Endocrinol. 11: 138–147.

    Caron KM, Soo SC, Wetsel WC, Stocco DM, Clark BJ, Parker KL 1997 Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc. Natl. Acad. Sci. USA. 94: 11540–11545

    Caron KM, Ikeda Y, Soo SC, Stocco DM, Parker KL, and Clark BJ. 1997 Characterization of the promoter region of the mouse gene encoding the steroidogenic acute regulatory protein. Mol. Endocrinol. 11: 138–147.

    Cherradi N, Brandenburger Y, Rossier MF, Vallotton MB, Stocco DM, Capponi AM. 1998 Atrial natriuretic peptide inhibits calciuminduced steroidogenic acute regulatory protein gene transcription in adrenal glomerulosa cells. Mol. Endocrinol. 12: 962–972.

    Chinery R, Brockman JA, Dransfield DT, Coffey RJ, 1997 Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein beta. A critical role for protein kinase A-mediated phosphorylation of Ser299. J. Biol. Chem. 272: 30356-30361.

    Christenson LK, Johnson PF, McAllister JM, Strauss JF. 1999 CCAAT/enhancer-binding proteins regulate expression of the human steroidogenic acute regulatory protem (StAR) gene. J. Biol. Chem. 274: 26591–26598.

    Christenson LK, Strauss JF. 2000. Steroidogenic acute regulatory protein (StAR) and the intramitochondrial translocation of cholesterol. Biochim. Biophys. Acta.1529: 175-187.

    Christenson LK, Osborne TF, McAllister JM, Strauss JF. 2001 Conditional response of the human steroidogenic acute regulatory protein gene promoter to sterol regulatory element binding proteinla. Endocrinology 142: 28–36.

    Clarke MS, Khakee R, McNeil P L, 1993 Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of immature and dystrophic muscle. J. Cell. Sci. 106: 121-133.

    Clark BJ, Wells J, King SR, Stocco DM. 1994 The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in 35
    MA-10 mouse Leydig tumor cells. J. Biol. Chem. 269: 28314–28322.

    Clark BJ, Soo SC, Caron KM, Ikeda Y, Parker KL, and Stocco DM. 1995 Hormonal and developmental regulation of the steroidogenic acute regulatory protein. Mol. Endocrinol. 9: 1346–1355

    Clark BJ, Pezzi V, Stocco DM, Rainey WE. 1995 The steroidogenic acute regulatory protein is induced by angiotensin II and K+ in H295R adrenocortical cells. Mol. Cell Endocrinol. 115: 215-19.

    Clark BJ, Combs R, Hales KH, Hales DB, Stocco DM. 1997 Inhibition of transcription affects synthesis of steroidogenic acute regulatory protein and steroidogenesis in MA-10 mouse Leydig tumor cells. Endocrinology 138:
    4893–4901.

    Clark BJ, Ranganathan V, Combs R. 2000 Post-translational regulation of steroidogenic acute regulatory protein by cAMP-dependent protein kinase A. Endocr. Res. 26: 681–689.

    Colvin JS, White AC, Pratt SJ, Ornitz DM. 2001a Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development 128: 2095–2106.

    Cooke BA, Ashford L, Abayasekara DR, Choi M. 1999 The role of chloride ions in the regulation of steroidogenesis in rat Leydig cells and adrenal cells. J. Steroid Biochem. Mol. Biol. 69: 359–365.

    Colvin JS, Green RP, Schmah J, Capel B, Ornitz DM. 2001b Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 104: 875–889.

    Constantinescu A, Wu M, Asher O, Diamond I. 2004 cAMP-dependent protein kinase type I regulates ethanol-induced cAMP response element-mediated gene expression via activation of CREB-binding protein and inhibition of MAPK. J. Biol .Chem. 279: 43321-43329.

    Dionne CA, Crumley G, Beliot F, Kaplow JM, Searfoss G, Ruta M, Burgess WH, Jaye M, Schlessinger J. 1990. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth
    factors. EMBO J. 9: 2685-2692.

    Doherty P, Walsh FS 1996 CAM-FGF Receptor Interactions: A Model for Axonal Growth. Mol Cell Neurosci 8:99-111.

    Epstein LF, Orme-Johnson NR, 1991 Regulation of steroid hormone biosynthesis. Identification of precursors of a phosphoprotein targeted to the mitochondrion in stimulated rat adrenal cortex cells. J. Biol. Chem. 266: 19739-19745.

    Ferguson JJ. 1963 Protein synthesis and adrenocorticotropin responsiveness. J. Biol. Chem. 238: 2754–2759.

    Flaumenhaft R, Moscatelli D, Rifkin DB. 1990 Heparin and heparin sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J. Cell Biol. 111: 1651-1659.

    Garces A, Nishimune H, Philippe JM, Pettmann B, DeLapeyriere O. 2000 FGF9: a motoneuron survival factor expressed by medial thoracic and sacral motoneurons. J. Neurosci. Res. 60: 1–9.

    Giri D, Ropiquet F, Ittmann M 1999 FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. J. Cell Physiol.
    180: 53–60.

    Gillespie LL, Chen G, Paterno GD. 1995 Cloning of a fibroblast growth factor receptor 1 splice variant from Xenopus embryos that lacks a protein kinase C site important for the regulation of receptor activity. J. Biol. Chem. 270: 22758–22763.

    Gyles SL, Burns CJ, Whitehouse BJ, Sugden D, Marsh PJ, Persaud SJ, Jones PM. 2001 ERKs regulate cyclic AMP-induced steroid synthesis through transcription of the steroidogenic acute regulatory (StAR) gene. J. Biol.
    Chem. 276(37): 34888-34895.

    Habert R, Lejeune H, Saez JM. 2001 Origin, differentiation and regulation of fetal and adult Leydig cells. Mol. Cell Endocrinol. 179: 47-74.

    Hammer GD, Krylova I, Zhang Y, Darimont BD, Simpson K, Weigel NL, Ingraham HA. 1999 Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and
    stress. Mol. Cell. 3(4): 521-526.

    Han IS, Sylvester SR, Kim KH, Schelling ME, Venkateswaran S, Blanckaert VD, McGuinness MP, Griswold MD. 1993 Basic fibroblast growth factor is a testicular germ cell product which may regulate Sertoli cell function. Mol. Endocrinol. 7: 889-97.

    Hecht D, Zimmerman N, Bedford M, Avivi A, Yayon A 1995 Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4. Growth
    Factors 12: 223–233.

    Herr AB, Ornitz DM, Sasisekharan R, Venkataraman G, Waksman G. 1997 Heparin-induced self-association of fibroblast growth factor 2. Evidence for two oligomerization processes. J. Biol. Chem. 272: 16382-16389.

    Hou JZ, Kan MK, McKeehan K, McBride G, Adams P, McKeehan WL. 1991 Fibroblast growth factor receptors from liver vary in three structural domains. Science 251: 665–668.

    Jin C, Wang F, Wu X, Yu C, Luo Y, McKeehan WL. 2004 Directionally Specific Paracrine Communication Mediated by Epithelial FGF9 to Stromal FGFR3 in Two-Compartment Premalignant Prostate Tumors. Cancer Research 64: 4555–4562.

    Kanda T, Iwasaki T, Nakamura S, Kurokawa T, Ikeda K, Mizusawa H. 2000 Self-secretion of fibroblast growth factor-9 supports basal forebrain cholinergic neurons in an autocrine/paracrine manner. Brain Res. 876: 22–30.

    Karim S, Berrou E, Levy-Toledano S, Bryckaert M, MacLouf J. 1997 Regulatory role of prostaglandin E2 in induction of cyclo-oxygenase-2 by a thromboxane A2 analogue (U46619) and basic fibroblast growth factor in porine aortic smooth-muscle cells. Biochem. J. 326: 593-599.

    King SR, Ronen-Fuhrmann T, Timberg R, Clark BJ, Orly J, Stocco DM. 1995 Steroid production after in vitro transcription, translation, and mitochondrial processing of protein products of complementary deoxyribonucleic acid for steroidogenic acute regulatory protein. Endocrinology 136: 5165–5176.

    Kirby JL, Yang L, Labus JC, Hinton BT. 2003 Characterization of Fibroblast Growth Factor Receptors Expressed in Principal Cells in the Initial Segment
    of the Rat Epididymis. Biology of reproduction 68: 2314–2321

    Laslett AL, McFarlane JR, Risbridger GP. 1997 Developmental response by Leydig cells to acidic and basic fibroblast growth factor. J. Steroid Biochem.
    Molec. Biol. 60: 171-179.

    Le T, Schimmer BP. 2001 The regulation of MAPKs in Y1 mouse
    adrenocortical tumor cells. Endocrinology 142: 4282–4287.

    Lin D, Sugawara T, Strauss III JF, Clark BJ, Stocco DM, Saenger P, Rogol A, Miller WL. 1995 Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267:1828–1831

    Lin XH, Buff EM, Perrimon N, Michelson AM. 1999 Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126: 3715-3723.

    Liu J, Hekkila P, Kahri A, Voutilainen R. 1996 Expression of the steroidogenic acute regulatory protein mRNA in adrenal tumors and cultured adrenal cells. J. Endocrinol. 150: 43–50.

    Lopez-Ilasaca M. 1998 Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades. Biochem. Pharmacol. 56: 269-77.

    Mach H, Volkin DB, Burke CJ, Middaugh CR, Linhardt RJ, Fromm JR, Loganathan D, Mattsson L. 1993 Nature of the interaction of heparin with acidic fibroblast growth factor. Biochemistry 32: 5480-5489.

    Manna PR, Kero J, Tena-Sempere M, Pakarinen P, Stocco DM, Huhtaniemi IT. 2001 Assessment of mechanisms of thyroid hormone action in mouse Leydig cells: regulation of the steroidogenic acute regulatory protein, steroidogenesis, and luteinizing hormone receptor function. Endocrinology
    142: 319–331.

    Manna PR, Dyson MT, Eubank DW, Clark BJ, Lalli E, Sassone- Corsi P. 2002 Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family. Mol. Endocrinol 16: 184–199.

    Manna PR, Huhtaniemi IT, Wang XJ, Eubank DW, Stocco DM. 2002

    Mechanisms of epidermal growth factor signaling: regulation of steroid biosynthesis and the steroidogenic acute regulatory protein in mouse Leydig tumor cells. Biol. Reprod. 67: 1393–1404.

    Manna PR, Eubank DW, Lalli E, Sassone-Corsi P, Stocco DM. 2003 Transcriptional regulation of the mouse steroidogenic acute regulatory protein gene by the cAMP response-element binding protein and steroidogenic factor 1. J. Mol. Endocrinol. 30: 381-397.

    Manna PR, Eubank DW, Stocco DM. 2003 Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene. Mol. Endocrinol. submitted for publication

    Manna PR, Stocco DM. 2005 Regulation of the steroidogenic acute regulatory protein expression: functional and physiological consequences. Curr. Drug Targets Immune. Endocr. Metabol. Disord. 5: 93–108.

    Mattei MG, Penault-Llorca F, Coulier F, Birnbaum D. 1995 The human FGF-9 gene maps to chromosomal region 13q11–q12. Genomics 29: 811–812.

    McKeehan WL, Wang F, Kan M. 1998 The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog Nucleic Acid Res Mol Biol 59: 135-176.

    Meyer TE, Habener JF. 1993 Cyclic adenosine 3_,5_-monophosphate response element binding protein (CREB) and related transcriptionactivating deoxyribonucleic acid-binding proteins. Endocr. Rev. 14: 269–290.

    Miller WL. 1988 Molecular biology of steroid hormone synthesis. Endocr. Rev. 9: 295–318.

    Miyamoto M, Naruo K, Seko C, Matsumoto S, Kondo T, Kurokawa T. 1993 Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol. Cell Biol. 13: 4251–4259.

    Miyake A, Konishi M, Martin FH, Hernday NA, Ozaki K, Yamamoto S, Mikami T, Arakawa T, Itoh N. 1998 Structure and expression of a novel member, FGF-16, of the fibroblast growth factor family. Biochem Biophys Res Commun. 243: 148-152

    Moscatelli D. 1987 High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary
    endothelial cells. J. Cell Physiol. 131: 123-130.

    Moy FJ, Safran M, Seddon AP, Kitchen D, Bohlen P, Aviezer D, Yayon A, Powers R. 1997 Properly oriented heparin-decasaccharideinduced dimers are the biologically active form of basic fibroblast growth factor. Biochemistry 36: 4782-4791.

    Nalbant D, Williams SC, Stocco DM, Khan SA. 1998 Luteinizing hormone-dependent gene regulation in Leydig cells may be mediated by CCAAT/enhancer-binding protein-beta. Endocrinology 139:272–279.

    Ohmachi S, Watanabe Y, Mikami T, Kusu N, Ibi T, Akaike A, Itoh N. 2000 FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain. Biochem. Biophys. Res. Commun. 277: 355-360.

    Ong SH, Guy GR, Hadari YR, Laks S, Gotoh N, Schlessinger J, Lax I. 2000 FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol. Cell Biol. 20: 979–989.

    Ornitz DM, Itoh N. 2001 Fibroblast growth factors. Genome Biol. 2: 1–12.

    Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P. 1992 Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell Biol. 12: 240-247.

    Ornitz DM. 2000 FGFs, heparan sulfate and FGFRs: complex interactions essential for development. BioEssays 22: 108-112.

    Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. 1996 Receptor specificity of the fibroblast growth factor family.J. Biol. Chem. 271: 15292–15297.

    Orr-Urtreger A, Bedford MT, Burakova T, Arman E, Zimmer Y, Yayon A, Givol D, Lonai P.1993 Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev. Biol. 158: 475–486.

    Osman H, Murigande C, Nadakal A, Capponi AM. 2002 Repression of DAX-1 and induction of SF-1 expression. Two mechanisms contributing to the activation of aldosterone biosynthesis in adrenal glomerulosa cells. J. Biol. Chem. 277: 41259–41267.

    Pezzi V, Clark BJ, Ando S, Stocco DM, Rainey WE. 1996 Role of calmodulin-dependent protein kinase II in the acute stimulation of aldosterone production. J. Steroid. Biochem. Mol. Biol. 58: 417–424.

    Ramnath HI, Peterson S, Michael AE, Stocco DM, Cooke BA. 1997 Modulation of steroidogenesis by chloride ions in MA-10 mouse tumor Leydig cells: roles of calcium, protein synthesis, and the steroidogenic acute regulatory protein. Endocrinology 138:2308–2314.

    Rapraeger AC, Krufka A, Olwin BB. 1991 Requirement of heparin sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252: 1705-1708.

    Reinhart AJ, Williams SC, Clark BJ, Stocco DM. 1999 SF-1 (steroidogenic factor-1) and C/EBP_ (CCAAT/enhancer binding protein-_) cooperate to regulate the murine StAR (steroidogenic acute regulatory) promoter. Mol. Endocrinol. 13:729–741.

    Reinhart AJ, Williams SC, Stocco DM. 1999 Transcriptional regulation of the StAR gene. Mol. Cell. Endocrinol. 151: 161–169.

    Reuss B, von Bohlen und Halbach O. 2003 Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res. 313: 139-57.

    Reinhart AJ, Williams SC, Stocco DM. 1999 Transcriptional regulation of the StAR gene. Mol. Cell. Endocrinology 151; 161-169.

    Reyland ME, Evans RM, Elizabeth KW. 2000 Lipoproteins regulate expression of the steroidogenic acute regulatory protein (StAR) in mouse adrenocortical cells. J. Biol. Chem. 275, 36637–36644.

    Richard Grose, Clive Dickson. 2005 Fibroblast growth factor signaling in tumorigenesis. Cytokine & Growth Factor Reviews 16: 179–186.

    Robinson MJ, Cobb MH. 1997 Mitogen-activated protein kinase pathways. Current Opinion in Cell Biology 9: 180–186.

    Rust W, Stedronsky K, Tillmann G, Morley S, Walther N, Ivell R. 1998 The role of SF-1/Ad4BP in the control of the bovine gene for the steroidogenic acute regulatory (StAR) protein. J. Mol. Endocrinol. 21: 189–200.

    Sandhoff TW, Hales DB, Hales KH, McLean MP. 1998 Transcriptional regulation of the rat steroidogenic acute regulatory protein gene by steroidogenic factor 1. Endocrinology 139: 4820–4831.

    Santos-Ocampo S, Colvin JS, Chellaiah A, Ornitz DM 1996 Expression and biological activity of mouse fibroblast growth factor-9. J. Biol. Chem. 271:1726–1731.

    Seger R, Hanoch T, Rosenberg R, Dantes A, Merz WE, Strauss JF. 2001 The ERK signaling cascade inhibits gonadotropinstimulated steroidogenesis. J. Biol. Chem. 276: 13957–13964.

    Seger R, Krebs EG. 1995 The MAPK signaling cascade. FASEB 9: 726–735.

    Silverman E, Eimerl S, Orly J. 1999 CCAAT enhancer-binding protein beta and GATA-4 binding regions within the promoter of the steroidogenic acute regulatory protein (StAR) gene are required for transcription in rat ovarian
    cells. J. Biol. Chem. 274: 17987–17996.

    Simpson ER, Waterman MR. 1988 Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu. Rev. Physiol. 50: 427–440.

    Song J, Slack JM. 1996 XFGF-9: a new fibroblast growth factor from Xenopus embryos. Dev. Dyn. 206: 427–436.

    Stocco DM, Sodeman TC. 1991 The 30-kDa mitochondrial proteins induced by hormone stimulation in MA-10 mouse Leydig tumor cells are processed from larger precursors. J. Biol. Chem. 266: 19731–19738.

    Stocco DM. 1998 Recent advances in the role of StAR. Rev. Reprod. 3: 82–85.

    Stocco DM. 2000 StARTing to understand cholesterol transfer. Nat. Struct. Biol. 7: 445–447.

    Stocco DM. 2000 The role of the StAR protein in steroidogenesis:challenges for the future. J. of Endrocrinol. 164: 247-253.

    Stocco DM. 2000 Intramitochondrial cholesterol transfer. Biochim. Biophys. Acta. 1486: 184–197.

    Stocco DM. 2001 Tracking the role of a star in the sky of the new millennium. Mol. Endocrinol.15: 1245-1254.

    Stocco DM, Clark BJ. 1996 Regulation of the acute production of steroids in steroidogenic cells. Endocr. Rev. 17: 221–244.

    Stocco DM, Clark BJ. 1996 Role of the steroidogenic acute regulatory protein (StAR) in steroidogenesis. Biochem. Pharmacol. 51: 197-205.

    Stocco DM, Clark BJ, Reinhart AJ, Williams SC, Dyson M, Dassi B. 2001 Elements involved in the regulation of the StAR gene. Mol. Cell. Endocrinol. 177: 55–59.

    Stocco DM, Kilgore MW. 1988 Induction of mitochondrial proteins in MA- 10 Leydig tumour cells with human choriogonadotropin. Biochem. J. 249: 95–103.

    Stocco DM, Sodeman TC. 1991 The 30-kDa mitochondrial proteins induced by hormone stimulation in MA-10 mouse Leydig tumor cells are processed from larger precursors. J. Biol. Chem. 266: 19731-19738.

    Stocco DM, Wang X, Jo Y, Manna PR. 2005 Multiple Signaling Pathways Regulating Steroidogenesis and Steroidogenic Acute Regulatory Protein Expression: More Complicated than We Thought. Mol. Endocrinol.19: 2647–2659.

    Strauss JF, Kishida T, Christenson LK, Fujimoto T, Hiroi H. 2003 START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol. Cell Endocrinol. 28: 59-65.

    Sugawara T, Holt JA, Driscoll D, Strauss JF, Lin D, Miller WL, Patterson D, Clancy KP, Hart IM, Clark BJ. 1995 Human steroidogenic acute regulatory protein: functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and a pseudogene to chromosome 13. PNAS. 92: 4778–4782.

    Sugawara T, Holt JA, Kiriakidou M, Strauss Jr JF. 1996 Steroidogenic factor 1-dependent promoter activity of the human steroidogenic acute regulatory protein (StAR) gene. Biochemistry 35: 9052–9059.

    Sugawara T, Kiriakidou M, McAllister JM, Holt JA, Arakane F, Strauss JF. 1997 Regulation of expression of the steroidogenic acute regulatory protein (StAR) gene: a central role for steroidogenic factor 1. Steroids 62: 5–9.

    Sugawara T, Kiriakidou M, McAllister JM, Kallen CB, Strauss JF. 1997 Multiple steroidogenic factor 1 binding elements in the human steroidogenic acute regulatory protein gene 5_-flanking region are required for maximal promoter activity and cyclic AMP responsiveness. Biochemistry 36: 7249–7255.

    Sugawara T, Saito M, Fujimoto S. 2000 Sp1 and SF-1 interact and cooperate in the regulation of human steroidogenic acute regulatory protein gene
    expression. Endocrinology 141: 2895–2903.

    Szebenyi G, Fallon JF. 1999 Fibroblast growth factors as multifunctional signaling factors. Int. Rev. Cytol. 185: 45-106.

    Tagashira S, Ozaki K, Ohta M, Itoh N. 1995 Localization of fibroblast growth factor-9 mRNA in the rat brain. Brain. Res. Mol. Brain. Res. 30: 233–241.

    Tremblay JJ, Hamel F, Viger RS. 2002 Protein kinase A-dependent cooperation between GATA and CCAAT/enhancer-binding protein transcription factors regulates steroidogenic acute regulatory protein
    promoter activity. Endocrinology 143: 3935–3945.

    Twigg SR, Burns HD, Oldridge M, Heath JK, Wilkie AO. 1998 Conserved use of a non-canonical 59 splice site (/GA) in alternative splicing by fibroblast growth factor receptors 1, 2 and 3. Hum. Mol. Genet. 7: 685–691.

    Vainikka S, Partanen J, Bellosta P, Coulier F, Birnbaum D, Basilico C, Jaye M, Alitalo K. 1992 Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction. EMBO
    J. 11: 4273–4280.

    Vanhaesebroeck B., Alessi DR. 2000 The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346: 561-576.

    Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D. 1996 Involvement of heparan sulfate and related molecules in sequestration and growthpromoting activity of fibroblast growth factor. Cancer Metastasis Rev. 15: 177-186.

    Wang X, Stocco DM. 1999 Cyclic AMP and arachidonic acid: a tale of two pathways. Mol. Cell. Endocrinol. 158: 7–12.

    Wang X, Walsh LP, Reinhart AJ, Stocco DM. 2000 The role of arachidonic acid in steroidogenesis and steroidogenic acute regulatory (StAR) gene and protein expression. J. Biol. Chem. 275: 20204–20209.

    Werner S, Duan DS, de Vries C, Peters KG, Johnson DE, Williams LT. 1992 Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligandbinding
    specificities. Mol. Cel. Biol. 12: 82–88.

    Wooton-Kee CR, Clark BJ. 2000 Steroidogenic factor-1 influences protein–deoxyribonucleic acid interactions within the cyclic adenosine 3,5-monophosphate-responsive regions of the murine steroidogenic acute regulatory protein gene. Endocrinology 141: 1345–1355.

    Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan WL. 1993 Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell Bio. 13: 4513–4522.

    Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. 1991 Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848.

    Zenkert S, Schubert B, Fassnacht M, Beuschlein F, Allolio B, Reincke M. 2000 Steroidogenic acute regulatory protein mRNA expression in adrenal tumours. Eur. J. Endocrinol. 142: 294–299.

    Zhao D, Duan H, Kim YC, Jefcoate CR. 2005 Rodent StAR mRNA is substantially regulated by control of mRNA stability through sites in the 3'-untranslated region and through coupling to ongoing transcription. J. Steroid Biochem. Mol. Biol. 962: 155-173.

    下載圖示 校內:2008-08-08公開
    校外:2008-08-08公開
    QR CODE